BROWN UNIVERSITY HEALTH (FKA LIFESPAN)

oppose DEA proposed rules on prescription drugs for behavioral health, support increase in CHGME and GME funding and training slots, oppose 340B impacts from pharmaceutical company actions re: contract pharmacies, support increases in Medicare reimbursements, DSH delays and legislation increasing GME slots and physician/workforce initiatives (e.g., HR2389). oppose site neutral cuts, expanding medicare telehealth, increase NIH funding, support employee retention credit timeframes, and provide targeted support for improving hospital discharges, oppose market basket reimbursement rates in Medicare proposed rules, support 3.021 (pulmonary rehab telehealth).